Juro Sciences株式会社

j2hbio

This company develops small molecule pharmaceuticals and provides contract manufacturing services to global pharmaceutical partners to treat rare and incurable diseases.

Stimuli

This company develops a medical device using transcutaneous electrical nerve stimulation to treat adults suffering from overactive bladder symptoms and urinary urgency.

BioTryp

This company develops oral antibiofilm therapies to treat bacterial infections for patients, primarily focusing on individuals with urinary tract infections.

AtoCap

This company develops biodegradable microcapsules for targeted drug delivery to treat recurrent infections and bladder cancer for pharmaceutical partners and clinical providers.

J-Pharma

This company develops small molecule drugs targeting SLC transporters for patients with biliary tract cancer and multiple sclerosis.

CuraSen Therapeutics

This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.

Amber Therapeutics

This company develops an implantable adaptive neuromodulation system to treat women suffering from mixed urinary incontinence.

SiccaNova Therapeutics

This biopharmaceutical company develops small-molecule therapeutics to treat medical conditions involving dryness, including xerostomia and dry eye, for patients with unmet medical needs.